I am very excited about the progress of PTX100, Prof Miles Prince is off to America again accompanied by the new Ceo James Mc Donnell. From memory this will be his fourth trip overseas in regard to PTX 100 in 15 months. When an internationally recognized Hematologist / Oncology Specialist of his caliber is showing a substantial amount of interest in PTX100 it deserves our attention as well, and l look forward to their update in regard to their trip. Also, maybe SYC was correct Prescient Therapeutics is not a one trick pony, it appears that Prof Phil Darcy from The Peter MacCallum Cancer Centre is still on track with OmniCar. l also wonder how OmniCar is going in regard to its investigation to treating Solid Tumours and not just Breast Cancer. Both Miles and Phil have the same interest and that to have a treatment that works and is more friendly than Chemo, I remind shareholders to be patient and focus on the results Prescient Therapeutics is achieving and the share price will look after itself. We are in an existence of achievement witnessing a possible cure for at least two types of Cancer. Regards Logan123
PTX Price at posting:
5.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)